Georg Thieme Verlag KG

Suchergebnisse zur Ihrer letzten Suchanfrage

1  August JR. Otitis externa: A disease of multifactorial etiology. Vet Clin North Am Small Anim Pract 1988; 18 (04) 731-742

2  Cole LK. Otoscopic Evaluation of the Ear Canal. Vet Clin North Am Small Anim Pract 2004; 34 (02) 397-410

3  Hill PB, Lo A, Eden CAN. et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 2006; 158: 533-539

4  Angus JC. Otic cytology in health and disease. Vet Clin North Am Small Anim Pract 2004; 34 (02) 411-424

5  Miller WH, Griffin CE, Campbell KL. Diseases of the eyelids, claws, anal sacs, and ears. In: Muller & Kirkʼs Small Animal Dermatology. Missouri: Elsevier; 2013: 724-773

6  Linek M. Otitis externa und media bei Hund und Katze. Tierärztl Prax 2011; 39 (06) 451-463

7  Saridomichelakis MN, Farmaki R, Leontides LS. et al. Aetiology of canine otitis externa: a retrospective study of 100 cases. Vet Dermatol 2007; 18: 341-347

8  Bischoff MG, Kneller SK. Diagnostic imaging of the canine and feline ear. Vet Clin North Am Small Anim Pract 2004; 34 (02) 437-458

9  Solano M. Diagnostic Imaging of the Ear. In: Small Animal ear diseases. An illustrated guide. St. Louis: Elsevier Saunders; 2005. (2). 77 110

10  Bouassiba C, Osthold W. Die Myringotomie bei Hund und Katze – ein einfaches Verfahren für die Praxis. Vet Spiegel 2014; 1: 12-17

11  Griffin CE. Cutaneous cytology. Proceedings of the 82nd Western Veterinary Conferences 2009; Las Vegas: T6. 2009

12  Hader C. Otitis externa beim Hund – Ergebnisse mikrobiologischer Untersuchungen von Ohrtupferproben inklusive Antibiotikaresistenztestung aus dem Jahr 2016. Kl Tier Prax 2020; 65 (06) 312-324

13  Rosser Jr. EJ. Causes of otitis externa. Vet Clin North Am Small Anim Pract 2004; 34: 459-468

14 Antibiotikaleitlinien. Bundestierärztekammer 2015.

15  Von Silva-Tarouca MSE, Wolf G, Mueller RS. Determination of minimum inhibitory concentrations for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolates from canine otitis externa. Vet Dermatol 2019; 30: 145-e42

16  Bouassiba C, Mueller RS. In-vivo-Wirksamkeit eines Ohrmedikamentes mit Gelatinepulver als Wirkstoffträger bei der Therapie kaniner Otitis externa. Tierärztl Prax 2017; 45 (04) 235-344

17  Ter Haar G. Ototocicity. Tiermedizinische Fortbildung „Ganz Ohr 2.0“. Mönchengladbach; 2013

18  Chiavassa E, Tizzani P, Peano A. In vitro Antifungal Susceptibility of Malassezia pachydermatis Strains Isolated from Dogs with Chronic and Acute Otitis Externa. Myco Path 2014; 178: 315-319

19  Bensignor E, Forsythe P. An approach to otitis externa. BSAVA Manual of Canine and Feline Dermatology 2012; 5: 110-120

20  Tresch M, Mevissen M, Ayrle H. et al. Medical plants as therapeutic options für topical treatment in canine dermatology? A systhemic review. BMC Veterinary Research 2019; 15: 174

21  Nakano Y, Wada M, Tani H. et al. Effects of β-Thujaplicin on Anti-Malassezia pachydermatis Remedy for Canine Otitis Externa. J Vet Med Sci 2005; 67 (12) 1243-1247

22  Feng Sim JX, Khazandi M, Chan WY. et al. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa. Vet Dermatol 2019; 30: 524-e159

23  Sim JXF, Khazandi M, Venter HP. et al. Antimicorbial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens. J of Appl Microb 2019; 127: 99-108

24  Kim A-H, Kim S, Jun H-K. et al. Efficacy of aromatherapy für the treatment of otitis externa in dogs. Korean J Vet Rest 2009; 1: 85-89

25  Fitzi J, Fürst-Jucker J, Wegener T. et al. Phytotherapy of chronic dermatitis and pruritus of dogs with a topical preparation containing tea tree oil (Bogaskin ® ) . Schweiz Arch Tierheilk 2002; 144 (05) 223-231

26  Maruhashi E, Sao Braz B, Nunes T. et al. Efficacy of medical grade honey in the treatment of canine otitis externa-a pilot study. Vet Dermatol 2016; 27: 93x-e27

27  Song S-Y, Hyun J-E, Kang J-K. et al. In vitro antibacterial activity oft he manuka essential oil from Leptospermum scoparium combined with Tris-EDTA against Gram-negative bacterial isolates from dogs with otitis externa. Vet Dermatol 2019; 31: 81-e6

28  Lozina LA, Peichoto MA, Boehringer SI. et al. Efficacy of Argentine propolis formulation for topical treatment of canine otitis externa. Arq Bras Med Vet Zootec 2010; 62 (06) 1359-1366

29  Fregeneda-Grandes JM, Nicolaz-Gonzales JJ, Rejas-Lopez J. et al. Preliminary evaluation of two commercial ear solutions in the treatment of canine otitis externa. J of Small Anim Pract 2020; 61: 547-553

30  Di Cerbo A, Centenaro S, Beribe F. et al. Clinical evaluation of an antiinflammatory and antioxidant diet in 30 dogs effected by chronic otitis externa: preliminary results. Vet Res Commun 2016; 40: 29-38

31  May ER, Conklin KA, Bremis DA. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates. Vet Dermatol 2016; 27: 188-e47

32  Chan WY, Khadanzi M, Hickey EE. et al. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa. Vet Dermatol 2018; 30: 133-382

33  Sellera FP, Fernandes MR, Sabino CP. et al. Effective treatment and decolonization of a dog infected with carbapenemase (VIM-2)-producing Pseudomonas aeruginosa using probiotic and photodynamic therapies. Vet Dermatol 2019; 30: 170-e52

34  Tambella ANM, Attili AR, Beribe F. et al. Management of otitis externa with an led-illumnated gel: a radomized controlled clinical trial in dogs. BMC Veterinary Research 2020;

1  Abramo F, Vercelli A, Mancianti F. Two cases of dermatophytic pseudomycetoma in the dog: an immunohistochemical study. Vet Dermatol 2001; 12: 203-207

2  Achten G. The use of detergents for direct mycologic examination. J Invest Dermatol 1956; 26: 389-397

3  Angarano DW, Scott DW. Use of ketoconazole in treatment of dermatophytosis in a dog. J Am Vet Med Assoc 1987; 190: 1433-1434

4  Asawanonda P, Taylor CR. Wood’s light in dermatology. Int J Dermatol 1999; 38: 801-807

5  Baldo A, Tabart J, Vermout S. et al. Secreted subtilisins of Microsporum canis are involved in adherence of arthroconidia to feline corneocytes. J Med Microbiol 2008; 57: 1152-1156

6  Baldo A, Monod M, Mathy A. et al. Mechanisms of skin adherence and invasion by dermatophytes. Mycoses 2012; 55: 218-223

7  Bayerl V. Prüfung der keimreduzierenden Wirkung eines Dampfreinigungsgerätes anhand mikrobiologischer Untersuchungen [Dissertation]. München: Ludwig-Maximilians-Universität; 2016

8  Bechter R, Schmid BP. Teratogenicity in vitro – a comparative study of four antimycotic drugs using the whole-embryo culture system. Toxicol In Vitro 1987; 1: 11-15

9  Berg JC, Hamacher KL, Roberts GD. Pseudomycetoma caused by Microsporum canis in an immunosuppressed patient: a case report and review of the literature. J Cutan Pathol 2007; 34: 431-434

10  Bergman RL, Medleau L, Hnilica K. et al. Dermatophyte granulomas caused by Trichophyton mentagrophytes in a dog. Vet Dermatol 2002; 13: 51-54

11  Bond R, Middleton DJ, Scarff DH. et al. Chronic dermatophytosis due to Microsporum persicolor infection in three dogs. J Small Anim Pract 1992; 33: 571-576

12  Bossche HV, Koymans L, Moereels H. P450 inhibitors of use in medical treatment: focus on mechanisms of action. Pharmacol Ther 1995; 67: 79-100

13  Breuer-Strosberg R. Reported frequency of dermatophytes in cats and dogs in Austria. Dtsch Tierarztl Wochenschr 1993; 100: 483-485

14  Cabanes FJ, Abarca ML, Bragulat MR. Dermatophytes isolated from domestic animals in Barcelona, Spain. Mycopathologia 1997; 137: 107-113

15  Cafarchia C, Romito D, Sasanelli M. et al. The epidemiology of canine and feline dermatophytoses in southern Italy. Mycoses 2004; 47: 508-513

16  Cafarchia C, Iatta R, Latrofa MS. et al. Molecular epidemiology, phylogeny and evolution of dermatophytes. Infect Genet Evol 2013; 20: 336-351

17  Căpitan R, Schievano C, Noli C. Evaluation of the value of staining hair samples with a modified Wright-Giemsa stain and/or showing illustrated guidelines for the microscopic diagnosis of dermatophytosis in cats. Vet Dermatol. 201818  Caplan RM. Medical uses of the Wood’s lamp. JAMA 1967; 202: 1035-1038

19  Carlotti D, Bensignor EJVD. Dermatophytosis due to Microsporum persicolor (13 cases) or Microsporum gypseum (20 cases) in dogs. Vet Dermatol. 2002 

20  Carlotti DN, Guinot P, Meissonnier E. et al. Eradication of feline dermatophytosis in a shelter: a field study. Vet Dematol 2010; 21: 259-266

21  Cerundolo R. Generalized Microsporum canis dermatophytosis in six Yorkshire terrier dogs. Vet Dematol 2004; 15: 181-187

22  Chen C, Su B. Concurrent hyperadrenocorticism in a minature schnauzer with severe Trichophyton mentagrophytes infection. Vet Dermatol 2002; 13: 211-229

23  Chiou WL, Riegelman S. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 1969; 58: 1505-1510

24  CliniPharm/CliniTox. Tierarzneimittel-Kompendium der Schweiz. (Zugriff am10.7.2019)

25  Cornegliani L, Persico P, Colombo S. Canine nodular dermatophytosis (kerion): 23 cases. Vet Dermatol 2009; 20: 185-190

26  Dasgupta T, Sahu J. Origins of the KOH technique. Clin Dermatol 2012; 30: 238-242

27  Davidson AM, Gregory PH. Note on an investigation into the fluorescence of hairs infected by certain fungi. Can J Res 1932; 7: 378-385

28  de Hoog GS, Dukik K, Monod M. et al. oward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia 2017; 182: 5-31

29  De Keyser H, Van den Brande M. Ketoconazole in the treatment of dermatomycosis in cats and dogs. Vet Q 1983; 5: 142-144

30  DeBoer DJ, Moriello KA. Inability of two topical treatments to influence the course of experimentally induced dermatophytosis in cats. J Am Vet Med Assoc 1995; 207: 52-57

31  DeBoer DJ, Moriello KA. Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats. Res Vet Sci 1995; 59: 110-113

32  Deplazes P, Gottstein B, Nett C. et al. Bekämpfung von Dermatophytosen bei Hunden und Katzen. Adaption der ESCCAP-Empfehlung Nr. 2 für die Schweiz. 03/2016

33  Di Mattia D, Fondati A, Monaco M. et al. Comparison of two inoculation methods for Microsporum canis culture using the toothbrush sampling technique. Vet Dermatol 2019; 30: 60-e17

34  Dong C, Angus J, Scarampella F. et al. Evaluation of dermoscopy in the diagnosis of naturally occurring dermatophytosis in cats. Vet Dermatol 2016; 27: 275-e265

35  Ellis D. Mycology Online. (Zugriff am 1.5.2019)

36  Filipello MV, Gallo MG, Tullio V. et al. Dermatophytes from cases of skin disease in cats and dogs in Turin, Italy. Mycoses 1995; 38: 239-244

37  Giner J, Bailey J, Juan-Sallés C. et al. Dermatophytic pseudomycetomas in two ferrets (Mustela putorius furo). Vet Dermatol 2018; 29: 452-e154

38  Gross TL, Ihrke PJ, Walder EJ. et al., eds. Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis. 2nd ed. Oxford: John Wiley & Sons; 2008

39  Grosso DS, Boyden TW, Pamenter RW. et al. Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins. Antimicrob Agents Chemother 1983; 23: 207-212

40  Guillot J, Rojzner K, Fournier C. et al. Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. Vet Rec 2002; 150: 714-718

41  Gull K, Trinci AP. Griseofulvin inhibits fungal mitosis. Nature 1973; 244: 292

42  Hall EJ, Miller WH, Medleau L. Ketoconazole treatment of generalized dermatophytosis in a dog with hyperadrenocorticism. J Am Anim Hosp Assoc 1984; 20: 597-602

43  Hawksworth DL, Crous PW, Redhead SA. et al. The amsterdam declaration on fungal nomenclature. IMA Fungus 2011; 2: 105-112

44  Hawksworth DL. A new dawn for the naming of fungi: impacts of decisions made in Melbourne in July 2011 on the future publication and regulation of fungal names. IMA Fungus 2011; 2: 155-162

45  Helton KA, Nesbitt GH, Caciolo PL. Griseovulvin toxicity in cats – literature review and report of 7 cases. J Am Anim Hosp Assoc 1986; 22: 453-458

46  Hill PB, Lo A, Eden CAN. et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 2006; 158: 533-539

47  Hnilica KA, Medleau L. Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. Vet Dematol 2002; 13: 23-28

48  Hoffmann HJ. Generation of a human allergic mast cell phenotype from CD133(+) stem cells. Methods Mol Biol 2014; 1192: 57-62

49  Hughes R, Chiaverini C, Bahadoran P. et al. Corkscrew hair: a new dermoscopic sign for diagnosis of tinea capitis in black children. Arch Dermatol 2011; 147: 355-356

50  Jaham C, Page N, Lambert AJ. et al. Enilconazole emulsion in the treatment of dermatophytosis in Persian cats: tolerance and suitability. Adv Vet Dermatol 1998; 3: 299-307

51  Klein MF, Beall JR. Griseofulvin: a teratogenic study. Science 1972; 175: 1483-1484

52  Kunkle GA, Meyer DJ. Toxicity of high doses of griseofulvin in cats. J Am Vet Med Assoc 1987; 191: 322-323

53  Lappin MAS. Ringworm (dermatophytosis). J Small Anim Pract 1998; 39: 362-366

54  Legendre AM, Rohrbach BW, Toal RL. et al. Treatment of blastomycosis with itraconazole in 112 dogs. J Vet Intern Med 1996; 10: 365-371

55  Lewis DT, Foil CS, Hosgood G. Epidemiology and clinical features of dermatophytosis in dogs and cats at Louisiana State University: 1981–1990. Vet Dermatol 1991; 2: 53-58

56  Lin AN, Reimer RJ, Carter DM. Sulfur revisited. J Am Acad Dermatol 1988; 18: 553-558

57  MacKay BM, Johnstone I, O’Boyle DA. et al. Severe dermatophyte infections in a dog and cat. Aust Vet Pract 1997; 27: 86-90

58  Mancianti F, Giannelli C, Bendinelli M. et al. Mycological findings in feline immunodeficiency virus-infected cats. J Med Vet Mycol 1992; 30: 257-259

59  Mancianti F, Nardoni S, Cecchi S. et al. Dermatophytes isolated from symptomatic dogs and cats in Tuscany, Italy during a 15-year-period. Mycopathologia 2003; 156: 13-18

60  Mason KV, Frost A, O’Boyle D. et al. Treatment of a Microsporum canis infection in a colony of Persian cats with griseofulvin and a shampoo containing 2 % miconazole, 2 % chlorhexidine, 2 % miconazole and chlorhexidine or placebo. Vet Dermatol 2000; 12: 55

61  Mc Nall EG. Biochemical studies on the metabolism of griseofulvin. Ann N Y Acad Sci 1960; 81: 657-661

62  Meason-Smith C, Diesel A, Patterson AP. et al. What is living on your dog’s skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis. FEMS Microbiol Ecol 2015; 91

63  Meason-Smith C, Diesel A, Patterson AP. et al. Characterization of the cutaneous mycobiota in healthy and allergic cats using next generation sequencing. Vet Dermatol 2017; 28: 71-e17

64  Meng J, Barnes CS, Rosenwasser LJ. Identity of the fungal species present in the homes of asthmatic children. Clin Exp Allergy 2012; 42: 1448-1458

65  Mignon BR, Losson BJ. Prevalence and characterization of Microsporum canis carriage in cats. J Med Vet Mycol 1997; 35: 249-256

66  Miller WHJ, Griffin CE, Campbell KL. eds. Mullers and Kirk’s Small Animal Dermatology. 7th ed. St. Louis, Missouri: Elsevier Mosby; 2013

67  Moriello KA, DeBoer DJ. Fungal flora of the coat of pet cats. Am J Vet Res 1991; 52: 602-606

68  Moriello KA, Deboer DJ. Fungal flora of the haircoat of cats with and without dermatophytosis. J Med Vet Mycol 1991; 29: 285-292

69  Moriello KA, DeBoer DJ. Environmental decontamination of Microsporum canis: in vitro studies using isolated infected cat hair. Agris 1998; 309-318

70  Moriello KA, Deboer DJ, Volk LM. et al. Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates. Vet Dermatol 2004; 15: 175-180

71  Moriello KA, Hondzo H. Efficacy of disinfectants containing accelerated hydrogen peroxide against conidial arthrospores and isolated infective spores of Microsporum canis and Trichophyton sp. Vet Dermatol 2014; 25: 191-e148

72  Moriello KA. Feline dermatophytosis: aspects pertinent to disease management in single and multiple cat situations. J Feline Med Surg 2014; 16: 419-431

73  Moriello KA. Kennel disinfectants for Microsporum canis and Trichophyton sp. Vet Med Int. 2015 

74  Moriello KA. Decontamination of laundry exposed to Microsporum canis hairs and spores. J Feline Med Surg 2016; 18: 457-461

75  Moriello KA. Dermatophytosis: decontamination recommendations. In: Little S. ed. August’s Consultations in Feline Internal Medicine, Vol. 7. St. Louis: Elsevier; 2016: 334-344

76  Moriello KA, Coyner K, Paterson S. et al. Diagnosis and treatment of dermatophytosis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 2017; 28: 266-e268

77  Moriello KA. In vitro efficacy of shampoos containing miconazole, ketoconazole, climbazole or accelerated hydrogen peroxide against Microsporum canis and Trichophyton species. J Feline Med Surg 2017; 19: 370-374

78  Moriello KA, Leutenegger CM. Use of a commercial qPCR assay in 52 high risk shelter cats for disease identification of dermatophytosis and mycological cure. Vet Dermatol 2018; 29: 66-e26

79  Mueller RS. Diagnosis and management of canine claw diseases. Vet Clin North Am Small Anim Pract 1999; 29: 1357-1371

80  Muller A, Guaguère E, Degorce-Rubiales F. et al. Dermatophytosis due to Microsporum persicolor: a retrospective study of 16 cases. Can Vet J 2011; 52: 385

81  Nam HS, Kim TY, Han SH. et al. Evaluation of therapeutic efficacy of medical shampoo containing terbinafine hydrochloride and chlorhexidine in dogs with dermatophytosis complicated with bacterial infection. J Biomed Res 2013; 14: 154-159

82  Nardoni S, Tortorano A, Mugnaini L. et al. Susceptibility of Microsporum canis arthrospores to a mixture of chemically defined essential oils: a perspective for environmental decontamination. Z Naturforsch 2015; 70: 15-24

83  Newbury S, Moriello K, Verbrugge M. et al. Use of lime sulphur and itraconazole to treat shelter cats naturally infected with Microsporum canis in an annex facility: an open field trial. Vet Dermatol 2007; 18: 324-331

84  Newbury S, Moriello KA. Feline dermatophytosis: steps for investigation of a suspected shelter outbreak. J Feline Med Surg 2014; 16: 407-418

85  Ogawa H, Summerbell RC, Clemons KV. et al. Dermatophytes and host defence in cutaneous mycoses. Med Mycol 1998; 36: 166-173

86  Paterson S. Miconazole/chlorhexidine shampoo as an adjunct to systemic therapy in controlling dermatophytosis in cats. J Small Anim Pract 1999; 40: 163-166

87  Pereira SA, Passos SRL, Silva JN. et al. Response to azolic antifungal agents for treating feline sporotrichosis. Vet Rec 2010; 166: 290-294

88  Perrins N, Bond R. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine. Vet Dematol 2003; 14: 99-102

89  Perrins N, Howell SA, Moore M. et al. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine. Vet Dermatol 2005; 16: 330-333

90  Poisson L, Mueller RS, Olivry T. Canine pustular dermatophytosis of the corneum mimicking pemphigus foliaceus. Pratique medicale et chirurgical de l animal de compagnie 1998; 33: 229-234

91  Polak KC, Levy JK, Crawford PC. et al. Infectious diseases in large-scale cat hoarding investigations. Vet J 2014; 201: 189-195

92  Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia 2008; 166: 295-306

93  Scarampella F, Zanna G, Peano A. et al. Dermoscopic features in 12 cats with dermatophytosis and in 12 cats with self-induced alopecia due to other causes: an observational descriptive study. Vet Dermatol 2015; 26: 282-e263

94  Schubach TM, Schubach A, Okamoto T. et al. Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998–2003). Med Mycol 2006; 44: 87-92

95  Scott DW, Paradis M. A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987–1988). Can Vet J 1990; 31: 830

96  Shelton GH, Grant CK, Linenberger ML. et al. Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection. J Vet Intern Med 1990; 4: 317-319

97  Sierra P, Guillot J, Jacob H. et al. Fungal flora on cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukemia virus. Am J Vet Res 2000; 61: 158-161

98  Sparkes AH, Gruffydd-Jones TJ, Shaw SE. et al. Epidemiological and diagnostic features of canine and feline dermatophytosis in the United Kingdom from 1956 to 1991. Vet Rec 1993; 133: 57-61

99  Sparkes AH, Robinson A, MacKay AD  . et al. A study of the efficacy of topical and systemic therapy for the treatment of feline Microsporum canis infection. J Feline Med Surg 2000; 2: 135-142

100  Symoens F, Jousson O, Packeu A. et al. The dermatophyte species Arthroderma benhamiae: intraspecies variability and mating behaviour. J Med Microbiol 2013; 62: 377-385

101  Taylor JW. One Fungus = One Name: DNA and fungal nomenclature twenty years after PCR. IMA Fungus 2011; 2: 113-120

102  Van Cauteren H, Heykants J, De Coster R. et al. Itraconazole: pharmacologic studies in animals and humans. Rev Infect Dis 1987; 9 (Suppl. 01) S43-46

103  Van den Bossche H, Willemsens G, Cools W. et al. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrob Agents Chemother 1980; 17: 922-928

104  Van Tyle JH. Ketoconazole; mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 1984; 4: 343-373

105  Vlaminck K, Engelen M. An overview of pharmacokinetic and pharmacodynamic studies in the development of itraconazole for feline Microsporum canis dermatophytosis. Adv Vet Dermatol 2005; 5: 130-136

106  Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995; 8: 240-259

107  White-Weithers N, Medleau L. Evaluation of topical therapies for the treatment of dermatophyte-infected hairs from dogs and cats. J Am Anim Hosp Assoc 1995; 31: 250-253

108  Wilcoxon F, McCallan SEA. The fungicidal action of sulphur: I. The alleged role of pentathionic acid. Phytopathology 1930; 20: 391-417

109  Willard MD, Nachreiner RF, Howard VC. et al. Effect of long-term administration of ketoconazole in cats. Am J Vet Res 1986; 47: 2510-2513

110  Willard MD, Nachreiner R, McDonald R. et al. Ketoconazole-induced changes in selected canine hormone concentrations. Am J Vet Res 1986; 47: 2504-2509

111  Willems L, Van der Geest R, De Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Pharm Ther 2001; 26: 159-169

112  Yokoi S, Sekiguchi M, Kano R. et al. Dermatophytosis caused by Trichophyton rubrum infection in a dog. J Dermatol 2010; 16: 211-215

113  Ziółkowska G, Tokarzewski S. Determination of antifungal activity of Enizol: a specific disinfecting preparation. Med Weter 2006; 62: 792-796

114  Zur G, White SD. Hyperadrenocorticism in 10 dogs with skin lesions as the only presenting clinical signs. J Am Anim Hosp Assoc 2011; 47: 419-427

[391] Alam N. Yoon KM. Lee TS. Lee UY. “Hypolipidemic Activities of Dietary Pleurotus ostreatus in Hypercholesterolemic Rats.“ Mycobiology 2011; 39 (1): S.45–51. PMID: 22783072

[392] Anandhi R., Annadurai T., Anitha TS., Muralidharan AR., Najmunnisha K., Nachiappan V., Thomas PA., Geraldine P: “Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats.“ J Pysiol Biochem 2012 Oct 27. PMID: 23104078

[393] Arora S., Goyal S., Balani J., Tandon S. “Enhanced antiproliferative effects of aqueous extracts of some medicinal mushrooms on colon cancer cells.“ Int J Med Mushrooms. 2013;15(3):301–14. PMID: 23662617

[394] Atli B., Yamac M. “Screening of medicinal higher Basidiomycetes mushrooms from Turkey for lovastatin production.“ Int J Med Mushrooms. 2012;14(2):149–59. PMID: 22506575

[395] Bobek P., Ginter E., Kuniak L., Babala J., Jurcovicova M., Ozdín L., Cerven J. “Effect of mushroom Pleurotus ostreatus and isolated fungal polysaccharide on serum and liver lipids in Syrian hamsters with hyperlipoproteinemia.“ Nutrition. 1991 Mar-Apr; 7(2):105–8. PMID 1802191

[396] Chu KT., Xia L., Ng TB. “Pleurostrin, an antifungal peptide from the oyster mushroom.“ Peptides. 2005 Nov; 26(11):2098–103. PMID: 15941607

[397] Deepalakshmni K., Mirunalini S. “Pleurotus ostreatus: an oyster mushroom with nutritional and medicinal properties. “ J Biochem Tech, 2014, 5(2): 718–726

[398] Facchini JM., Alves EP., Aguilera C., Gern RM., Silveira ML., Wisbeck E., Furlan SA. “ Antitumor activity of Pleurotus ostreatus polysaccharide fractions on Ehrlich tumor and Sarcoma 180.“ Int J Biol Macromol. 2014 Apr; 68C:72–77. PMID: 24768967

[399] Hossain S., Hashimoto M., Choudhury EK., Alam N., Hussain S., Hasan M., Choudhury SK., Mahmud I. “Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats.“ Clin Exp Pharmacol Physiol 2003; 30: 470–5. PMID: 12823261

[400] Iwalokun B. A., Usen U. A., Otunba A. A., Olukoya D. K. “Comparative phytochemical evaluation, antimicrobial and antioxdant properties of Pleurotus ostreatus“ 2007 African Jornal of Biotechnology , Vol. 6 (15), pp 1732–1739

[401] Jayakumar T., Sakthivel M., Thomas PA., Geraldine P. “Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain.“ Chem Biol Interact 2008 Nov; 176 (2–3): 108–20. PMID: 18786523

[402] Jayakumar T., Thomas PA., Isai M., Geraldine P. “An extract of the oyster mushroom, Pleurotus ostreatus, increases catalase gene expression and reduces protein oxidation during aging in rats.“ Journal of Chinese integrative Medicin, 2010 Aug; 8 (8): 774–80. PMID: 20727333

[403] Jayasuriya WJ., Wanigatunge CA., Fernando GH., Abeytunga DT., Suresh TS. “Hypoglycaemic Activity of Culinary Pleurotus ostreatus and P. cystidiosus Mushrooms in Healthy Volunteers and Type 2 Diabetic Patients on Diet Control and the Possible Mechanisms of Action.“ Phytother Res. 2015 Feb;29(2):303–9. PMID: 25382404

[404] Jedinak A., Dudhgaonkar S., Wu QL., Simon J., Sliva D. “Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-KappaB and AP-1 signaling.“ Nutr J. 2011 May 16;10:52 PMID: 21575254

[405] Jedinak A., Dudhgaonkar S., Jiang J., Sandusky G., Sliva D. “Pleurotus ostreatus inhibits colitis-related colon carcinogenesis in mice.“ Int J Mol Med. 2010 Nov; 26(5):643–50. PMID: 20878085

[406] Jedinak A., Sliva D. “Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.“ Int J Oncol 2008 December; 33(6): 1307–1313. PMID: 19020765

[407] Jesenak M., Hrubisko M., Majtan J., Rennerova Z., Banovcin P. “Anti-allergic effect of Pleuran (beta-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.“ Phytother Res. 2014 Mar; 28(3):471–4. PMID: 23744488

[408] Karacsonyi S., Kuniak L. “Polysaccharides of Pleurotus ostreatus: Isolation and structure of pleuran, an alkali-insoluble beta-d-Glucan. “ Corbohydrate Polymers, 1994, Vol. 24, Issue 2, P. 107–111

[409] Maiti S., Mallick SK., Bhutia SK., Behera B., Mandal M., Maiti TK. “ Antitumor effect of culinary-medicinal oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., derived protein fraction on tumor-bearing mice models.“ Int J Med Mushrooms. 2011; 13(5):427–40. PMID: 22324408

[410] Sarangi I., Ghosh D., Bhutia SK., Mallick SK., Maiti TK. “Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans.“ Int Immunopharmacol. 2006 Aug; 6(8):1287–97. PMID: 16782541

[411] Silva S., Martins S, Karmali A., Rosa E. “Production purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity.“ J Sci Food Agric 2012 July; 92 (9): 1826–32. PMID: 22234986

[412] Wolff ER., Wisbeck E., Silveira ML., Gern RM., Pinho MS., Furlan SA. “Antimicrobial and antineoplasic activity of Pleurotus ostreatus.“ Appl Biochem Biotechnol. 2008 Dec; 151(2–3):402–12. PMID:18830827

[413] Yang Q., Huang B., Li H., Zhang C., Zhang R., Huang Y., Wang J. “Gastroprotective activities of a polysaccharide from the fruiting bodies of Pleurotus ostreatus in rats.“ Int J Biol Macromol. 2012 Jun; 50(5):1224–8. PMID: 22484446

[414] Yoshioka Y., Ikekawa T., Nida M., Fukuoka F. “Studies on antitumor activity of some fractions from basidiomyces.I. An antitumor acidic polysaccharide fraction of P. ostreatus (Fr.)“ 1972 Quél. Chem Pharm Bull (Tokyo) 20:1175–1180

[536] Ikekawa T. et al. "Anti-tumor Activity of Aqueous Extracts of Edible Mushrooms."Cancer Res 29(1969): 743–735

[553] Razumov IA., Kazachinskaia EI., Puchkova LI., Kosogorova TA., Gorbunova IA., Loktev VB., Tepliakova TV. “Protective activity of aqueous extracts from higher mushrooms against Herpes simplex virus type-2 on albino mice model“ Antibiot Khimioter. 2013; 58(9–10):8–12. PMID: 24738237

[570] Cohen N., Cohen J., Asatiani MD., Varshney VK., Yu HT., Yang YC., Li YH., Mau JL., Wasser SP. “Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms.“ Int J Med Mushrooms. 2014; 16(3):273–91. PMID: 24941169

[583] Mori K., Toyomasu T., Nanba H., Kuroda H. “Antitumor action of fruit bodies of edible mushrooms orally administered to mice.“ 1989, Mushroom Sci 12(1): 653–660

[603] Woo KJ., Jeong YJ., Park JW., Kwon TK. “Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells.“ Biochem Biophys Res Commun. 2004 Dec; 325(4):1215–22. PMID: 15555556

[641] Yan H., Chang H. “Antioxidant and antitumor activities of selenium- and zinc-enriched oyster mushroom in mice.“ Biol Trace Elem Res. 2012 Dec; 150(1–3):236–41. PMID: 22639385

[647] Xu B., Li C., Sung C. “Telomerase inhibitory effects of medicinal[18] mushrooms and lichens, and their anticancer activity.“ Int J Med Mushrooms. 2014; 16(1):17–28

[1] Bijsmans ES, Doig M, Jepson RE et al. Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats. J Vet Intern Med 2016; 30 (5): 1630–1636

[2] Braun JP, Lefebvre HP, Watson AD. Creatinine in the dog: a review. Vet Clin Pathol 2003; 32 (4): 162–179

[3] Brown CA, Elliott J, Schmiedt CW et al. Chronic Kidney Disease in Aged Cats. Vet Path 2016; 53 (2): 309–326

[4] Chakrabarti S, Syme HM, Elliott J. Clinicopathological Variables Predicting Progression of Azotemia in Cats with Chronic Kidney Disease. J Vet Intern Med 2012; 26 (2): 275–281

[5] Chalhoub S, Langston CE, Eatroff A. Anemia of renal disease. J Fel Med Surg 2011; 13 (9): 629–460

[6] Chalhoub S, Langston CE, Farrelly J. The Use of Darbepoetin to Stimulate Erythropoiesis in Anemia of Chronic Kidney Disease in Cats: 25 Cases. J Vet Intern Med 2012; 26 (2): 363–369

[7] Chew DJ, DiBartola SP, Schenck P. Chapter 5 - Chronic Renal Failure. In: Chew DJ, DiBartola SP, Schenck P, Hrsg. Canine and feline nephrology and urology. St. Louis, Missouri: Elsevier Saunders; 2011: 145–196

[8] Elliott J, Barber P, Syme H. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 2001; 42 (3): 122–129

[9] Finco DR, Brown SA, Vaden SL et al. Relationship between plasma creatinine concentration and glomerular filtration rate in dogs. J Vet Pharmacol Ther 1995; 18 (6): 418–421

[10] Hall JA, Obare E, Yerramilli M et al. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med 2014; 28 (6): 1676–1683

[11] International Renal Interest Society. IRIS staging system and treatment recommendations for cats and dogs. Available at: www. Accessed March 1, 2017

[12] IRIS Canine GN Study Group Standard Therapy Subgroup, Brown S, Elliott J, Francey T, Polzin D, VADEN S. Consensus Recommendations for Standard Therapy of Glomerular Disease in Dogs. J Vet Intern Med 2013; 27: S27–S43

[13] Jepson ER. Feline Systemic Hypertension. J Fel Med Surg 2011; 13 (1): 25–34

[14] Jepson RE, Brodbelt D, Vallance C et al. Evaluation of Predictors of the Development of Azotemia in Cats. J Vet Intern Med 2009; 23 (4): 806–813

[15] Jepson RE, Hartley V, Mendl M et al. A comparison of CAT Doppler and oscillometric Memoprint machines for non-invasive blood pressure measurement in conscious cats. J Fel Med Surg 2005; 7 (3): 147–152

[16] Jewell DE, Yu S, Yerramilli M et al. In Geriatric Cats Symmetric Dimethylarginine (SDMA) Responds to Changes in GFR Whereas Serum Creatinine Responds to Changes in Lean Body Mass. Abstract ACVIM Forum 2014, Nashville

[17] Maggio F, Defrancesco TC, Atkins CE, Pizzirani S, Gilger BC, Davidson MG. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985–1998). J Am Vet Med Assoc 2000; 217 (5): 695–702

[18] Mansfield KE, Nitsch D, Smeeth L et al. Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ 2016; 6 (12): e012690.

[19] O’Neill DG, Church DB, McGreevy PD et al. Prevalence of disorders recorded in cats attending primary-care veterinary practices in England. Vet J 2014; 202 (2): 286–291

[20] O’Neill DG, Elliott J, Church DB et al. Chronic kidney disease in dogs in UK veterinary practices: prevalence, risk factors, and survival. J Vet Intern Med 2013; 27 (4): 814–821

[21] Sent U, Gössl R, Elliott J et al. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease. J Vet Intern Med 2015; 29 (6): 1479–1487

[22] Steinbach S, Neiger R. Die chronische Nierenerkrankung der Katze: Stadieneinteilung und Behandlung anhand der Richtlinien der International Renal Interest Society. Kleintierprax 2012; 57 (9): 485–502

[23] Syme H. Hypertension in Small Animal Kidney Disease. Vet Clin North Am Small Anim Pract 2011; 41 (1): 63–89

[24] Syme HM, Barber PJ, Markwell PJ et al. Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 2002; 220 (12): 1799–1804

[25] Syme HM, Markwell PJ, Pfeiffer D et al. Survival of Cats with Naturally Occurring Chronic Renal Failure Is Related to Severity of Proteinuria. J Vet Intern Med 2006; 20 (3): 528–535

[26] Tomlinson LA, Abel GA, Chaudhry AN et al. ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLOS ONE. 2013; 8 (11): e78465.

[27] Polzin DJ. Chronic Kidney Disease. In: Ettinger SJ, Feldman EC, Hrsg. Textbook of Veterinary Internal Medicine: diseases of the dog and the cat. 7 ed. St. Louis, Missouri: Saunders Elsevier; 2010: 1990–2021

[28] Quimby JM. Update on Medical Management of Clinical Manifestations of Chronic Kidney Disease. Vet Clin North Am Small Anim Pract 2016; 46 (6): 1163–1181

1 Ettinger SJ, Feldmann EC. ed. Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat. St. Louis, Missouri: Elsevier; 2017
2 Peterson ME, Kintzer PP, Kass PH. Pretreatment clinical and laboratory findings in dogs with hypoadrenocorticism: 225 cases (1979–1993). J Am Vet Med Assoc 1996; 208 (01) 85-91
3 Frank CB, Valentin SY, Scott-Moncrieff JC. et al. Correlation of inflammation with adrenocortical atrophy in canine adrenalitis. J Comp Pathol 2013; 149 (2 – 3): 268-279
4 Anderson JR, Goudie RB, Gray KG. et al. Auto-antibodies in Addisonʼs disease. Lancet 1957; 272: 1123-1124
5 Boag AM, Christie MR, McLaughlin KA. et al. A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addisonʼs disease). Vet Immunol Immunopathol 2018; 202: 41-45
6 Friedenberg SG, Lunn KF, Meurs KM. Evaluation of the genetic basis of primary hypoadrenocorticism in Standard Poodles using SNP array genotyping and whole-genome sequencing. Mamm Genome 2017; 28 (1 – 2): 56-65
7 Buckley ME, Chapman PS, Walsh A. Glucocorticoid-deficient hypoadrenocorticism secondary to intravascular lymphoma in the adrenal glands of a dog. Aust Vet J 2017; 95 (03) 64-67
8 Béguin JS, Chevallier L, Rannou B. et al. Primary hypoaldosteronism in a dog with pituitary and adrenal T-cell lymphoma. J Small Anim Pract 2018; DOI: 10.1111/jsap.12955.
9 Kook PH, Grest P, Raute-Kreinsen U. et al. Addisonʼs disease due to bilateral adrenal malignancy in a dog. J Small Anim Pract 2010; 51 (06) 333-336
10 Hernandez-Bures A, White AG, Riordan L. Presumptive iatrogenic hypoadrenocorticism induced by high-dose ketoconazole administration in a dog. J Vet Intern Med 2019; 33 (05) 2235-2238
11 Kempker K, Güssow A, Neiger R. Transient, secondary hypoadrenocorticism after treatment with delmadinone acetate (Tardastrex®) in a two year old male dog. Schweiz Arch Tierheilkd 2016; 158 (03) 193-197
12 Thompson AL, Scott-Moncrieff JC, Anderson JD. Comparison of classic hypoadrenocorticism with glucocorticoid-deficient hypoadrenocorticism in dogs: 46 cases (1985–2005). J Am Vet Med Assoc 2007; 230 (08) 1190-1194
13 Lifton SJ, King LG, Zerbe CA. Glucocorticoid deficient hypoadrenocorticism in dogs: 18 cases (1986–1995). J Am Vet Med Assoc 1996; 209 (12) 2076-2081
14 Baumstark ME, Nussberger J, Boretti FS. et al. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone. J Vet Intern Med 2014; 28 (05) 1471-1478
15 Platt SR, Chrisman CL, Graham J. et al. Secondary hypoadrenocorticism associated with craniocerebral trauma in a dog. J Am Anim Hosp Assoc 1999; 35 (02) 117-122
16 Lathan P, Thompson AL. Management of hypoadrenocorticism (Addisonʼs disease) in dogs. Vet Med (Auckl) 2018; 9 (09) 1-10
17 Hanson JM, Tengvall K, Bonnett BN. et al. Naturally occuring adrenocortical insufficiency – an epidemiological study based on a Swedish-insured dog population of 525,028 dogs. J Vet Intern Med 2016; 30 (01) 76-84
18 Haviland RL, Toaff-Rosenstein RL, Reeves MP. et al. Clinical features of hypoadrenocorticism in soft-coated wheaten terrier dogs: 82 cases (1979–2013). Can Vet J 2016; 57 (04) 387-394
19 Shaker E, Hurvitz AI, Peterson ME. Hypoadrenocorticism in a family of Standard poodles. J Am Vet Med Assoc 1988; 192 (08) 1091-1092
20 Oberbauer AM, Bell JS, Belanger JM. et al. Genetic evaluation of Addisonʼs disease in the Portuguese Water Dog. BMC Vet Res 2006; 2: 2-15
21 Oberbauer AM, Benemann KS, Belanger JM. et al. Inheritance of hypoadrenocorticism in bearded collies. Am J Vet Res 2002; 63 (05) 643-647
22 Melián C, Peterson MC. Diagnosis and treatment of naturally occurring hypoadrenocorticism in 42 dogs. J Small Anim Pract 1996; 37 (06) 268-275
23 Wakayama JA, Furrow E, Merkel LK. et al. A retrospective study of dogs with atypical hypoadrenocorticism: a diagnostic cut-off or continuum?. J Small Anim Pract 2017; 58 (07) 365-371
24 Adler JA, Drobatz KJ, Hess RS. Abnormalities of serum electrolyte concentrations in dogs with hypoadrenocorticism. J Vet Intern Med 2007; 21 (06) 1168-1173
25 Nielsen L, Bell R, Zoia A. et al. Low ratios of sodium to potassium in the serum of 238 dogs. Vet Rec 2008; 162 (14) 431-435
26 Seth M, Drobatz KJ, Church DB. et al. White blood cell count and the sodium to potassium ratio to screen for hypoadrenocorticism in dogs. J Vet Intern Med 2011; 25 (06) 1351-1356
27 Ruckstuhl N, Hoerauf A, Tomsa K. et al. Pseudohypoadrenocorticism in two Siberian huskies with gastrointestinal parasitoses. Schweiz Arch Tierheilkd 2002; 144 (02) 75-81
28 Venco L, Valenti V, Genchi M. et al. A dog with pseudo-addison disease associated with trichuris vulpis infection. J Parasitol Res 2011; 2011: 68203
29 Wenger M, Mueller C, Kook PH. et al. Ultrasonographic evaluation of adrenal glands in dogs with primary hypoadrenocorticism or mimicking diseases. Vet Rec 2010; 167 (06) 207-210
30 Melián C, Stefanacci J, Peterson ME. et al. Radiographic findings in dogs with naturally-occuring primary hypoadrenocorticism. J Am Anim Hosp Assoc 1999; 35 (03) 208-212
31 Gold AJ, Langlois DK, Refsal KR. Evaluation of basal serum or plasma cortisol concentrations for the diagnosis of hypoadrenocorticism in dogs. J Vet Intern Med 2016; 30 (06) 1798-1805
32 Lathan P, Moore GE, Zambon S. et al. Use of a low-dose ACTH stimulation test for diagnosis of hypoadrenocorticism in dogs. J Vet Intern Med 2008; 22: 1070-1073
33 Richartz J, Neiger R. Hypoadrenocorticism without classic electrolyte abnormalities in seven dogs. Tierarztl Prax Ausg K Kleintiere Heimtiere 2011; 39 (03) 163-169
34 Lathan P, Scott-Moncrieff JC, Wills RW. Use of the cortisol-to-ACTH ratio in diagnosis of primary hypoadrenocorticism in dogs. J Vet Intern Med 2014; 28 (05) 1546-1550
35 Boretti FS, Meyer F, Burkhardt WA. et al. Evaluation of the cortisol-to-ACTH ratio in dogs with hypoadrenocorticism, dogs with diseases mimicking hypoadrenocorticism and in healthy dogs. J Vet Intern Med 2015; 29 (05) 1335-1341
36 Javadi S, Galac S, Boer P. et al. Aldosterone-to-renin and cortisol-to-adrenocorticotropic hormone ratios in healthy dogs and dogs with primary hypoadrenocorticism. J Vet Intern Med 2006; 20 (03) 556-561
 37 Schaer M. The treatment of acute adrenocortical insufficiency in the dog. J Vet Emerg Crit Care 2001; 11 (01) 7-14
38 Feldmann EC, Nelson RW, Reusch C, Scott-Moncrieff JC. Canine and Feline Endocrinology. 4th ed. London: Elsevier Saunders; 2014
39 Brady CA, Vite CH, Drobatz KJ. Severe neurologic sequelae in a dog after treatment of hypoadrenal crisis. J Am Vet Med Assoc 1999; 215 (02) 222-225 210
40 MacMillan KL. Neurologic complications following treatment of canine hypoadrenocorticism. Can Vet J 2003; 44 (06) 490-492
41 Klein SC, Peterson ME. Canine hypoadrenocorticism: part 2. Can Vet J 2010; 51 (02) 179-184
42 Gunn E, Shiel RE, Mooney CT. Hydrocortisone in the management of hypoadrenocorticism in dogs: a retrospective series of 30 cases. J Small Anim Pract 2016; 57: 227-233
43 Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance in Addisonʼs disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992; 75 (01) 259-264
44 Bates JA, Shott S, Schall WD. Lower initial dose desoxycorticosterone pivalate for treatment of canine primary hypoadrenocorticism. Aust Vet J 2013; 91 (03) 77-82
45 Kintzer PP, Peterson ME. Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism. J Vet Intern Med 1997; 11 (02) 43-49
46 Sieber-Ruckstuhl NS, Reusch CE, Hofer-Inteeworn N. et al. Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism. J Vet Intern Med 2019; 33: 1266-1271
47 Jaffey JA, Nurre P, Cannon AB. et al. Desoxycorticosterone pivalate duration of action and individualized dosing intervals in dogs with primary hypoadrenocorticism. J Vet Intern Med 2017; 31 (06) 1649-1657
48 Spence S, Gunn E, Ramsey I. Diagnosis and treatment of canine hypoadrenocorticism. In Practice 2018; 40: 281-290
49 Roberts E, Boden LA, Ramsey IK. Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism. Vet Rec 2016; 179 (04) 98
50 Zeugswetter FK, Haniger T. Prednisolon dosages in Addisonian dogs after integration of ACTH measurement into treatment surveillance. Tierarztl Prax Ausg K Kleintiere Heimtiere 2018; 46 (02) 90-96


1  Scott-Moncrieff JC. Hypothyroidism. In: Feldman EC, Nelson RW, Reusch CE. et al., eds. Canine and Feline Endocrinology. 4th ed. St. Louis, Missouri, USA: Elsevier; 2014: 77-135
2  Kaptein EM, Hays MT, Ferguson DC. Thyroid hormone metabolism. A comparative evaluation. Vet Clin North Am Small Anim Pract 1994; 24: 431-466 
3  Scott-Moncrieff JC. Hypothyroidism. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, Missouri, USA: Saunders Elsevier; 2010: 1751-1761
4  Nelson RW. Canine Hypothyreose. In: Nelson RW, Couto CG. Innere Medizin der Kleintiere. 2. Aufl. München: Elsevier GmbH, Urban & Fischer; 2010: 755-773
5  Kemppainen RJ, Clark TP. Etiopathogenesis of Canine Hypothyroidism. Vet Clin North Am Small Anim Pract 1994; 24: 467-476 
6  Scott-Moncrieff CR, Guptill-Yoran L. Hypothyroidism. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine. 5th ed. Philadelphia, PA, USA: Saunders; 2000: 1419-1429
7  Ferguson DC. Testing for Hypothyroidism in Dogs. Vet Clin North Am Small Anim Pract 2007; 37: 647-669 
8  Graham PA, Refsal KR, Nachreiner RF. Etiopathologic Findings of Canine Hypothyroidism. Vet Clin North Am Small Anim Pract 2007; 37: 617-631 
9  Brömel C, Pollard RE, Kass PH. et al. Ultrasonographic Evaluation of the Thyroid Gland in Healthy, Hypothyroid, and Euthyroid Golden Retrievers with Nonthyroidal Illness. J Vet Intern Med 2005; 19: 499-506 
10  Miller J, Popiel J, Chełmońska-Soyta A. Humoral and Cellular Immune Response in Canine Hypothyroidism. J Comp Pathol 2015; 153: 28-37 
11  Gessl A, Wilfing A, Agis H. et al. Activated Naive CD4 + Peripheral Blood T Cells in Autoimmune Thyroid Disease. Thyroid 1995; 5: 117-123 
12  Mazziotti G, Sorvillo F, Naclerio C. et al. Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto’s thyroiditis. Eur J Endocrinol 2003; 148: 383-388 
13  Colin IM, Isaac J, Dupret P. et al. Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 2004; 18: 72-76
14  Nachreiner RF, Refsal KR, Graham PA. et al. Prevalence of autoantibodies to thyroglobulin in dogs with nonthyroidal illness. Am J Vet Res 1998; 59: 951-955
15  Nachreiner RF, Refsal KR, Graham PA. et al. Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. J Am Vet Med Assoc 2002; 220: 466-471 
16  Åhlgren J, Uimari P. Heritability of hypothyroidism in the Finnish Hovawart population. Acta Vet Scand 2016; 58: 1-5 
17  Jaggy A, Oliver JE. Neurologic Manifestations of Thyroid Disease. Vet Clin North Am Small Anim Pract 1994; 24: 487-494 
18  Costa GM, Araujo SL, Xavier Júnior FAF. et al. Dermatological manifestations associated with canine hypothyroidism: A review. Rev Bras Hig e Sanidade Anim 2016; 10: 781-797 
19  Credille KM, Slater MR, Moriello KA. et al. The effects of thyroid hormones on the skin of beagle dogs. J Vet Intern Med 2001; 15: 539-546 
20  Jaggy A, Oliver JE, Ferguson DC. et al. Neurological Manifestations of Hypothyroidism: A Retrospective Study of 29 Dogs. J Vet Intern Med 1994; 8: 328-336 
21  Vitale CL, Olby NJ. Neurologic Dysfunction in Hypothyroid, Hyperlipidemic Labrador Retrievers. J Vet Intern Med 2007; 21: 1316-1322 
22  Rossmeisl JH, Duncan RB, Inzana KD. et al. Longitudinal study of the effects of chronic hypothyroidism on skeletal muscle in dogs. Am J Vet Res 2009; 70: 879-889 
23  Indrieri RJ, Whalen LR, Cardinet GH. et al. Neuromuscular abnormalities associated with hypothyroidism and lymphocytic thyroiditis in three dogs. J Am Vet Med Assoc 1987; 190: 544-548
24  Lauinger IB. Geräuschempfindlichkeit beim Hund am Beispiel des Bearded Collies – Ein Vergleich von Verhaltenstherapiemaßnahmen und Substitution mit Thyroxin [Dissertation]. München: Ludwig-Maximilians-Universität; 2012. 
25  Camps T, Amat M, Manteca X. A Review of Medical Conditions and Behavioral Problems in Dogs and Cats. Animals 2019; 9: 1133 
26  Tidholm A, Haggstrom J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res 2001; 62: 961-967 
27  Tidholm A, Falk T, Gundler S. et al. Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: A double-blind, placebo-controlled trial. Res Vet Sci 2003; 75: 195-201 
28  Beier P, Reese S, Holler PJ. et al. The role of hypothyroidism in the etiology and progression of dilated cardiomyopathy in doberman pinschers. J Vet Intern Med 2015; 29: 141-149 
29  Guglielmini C, Berlanda M, Fracassi F. et al. Electrocardiographic and echocardiographic evaluation in dogs with hypothyroidism before and after levothyroxine supplementation: A prospective controlled study. J Vet Intern Med 2019; 33: 1935-1942 
30  Kim Y-H, Kim J-H, Lee H-S. et al. A case of hypothyroidism concurrent with myxedema coma in a Cocker spaniel dog. Korean J Vet Serv 2012; 35: 159-163 
31  Feldman EC. Hypothyroidism. In: Feldman EC, Nelson RW. eds. Canine and Feline Endocrinology and Reproduction. 3 rd ed. St. Louis, MO: Elsevier; 2003: 86-151
32  Mesich MLL, Mayhew PD, Paek M. et al. Gall bladder mucoceles and their association with endocrinopathies in dogs: A retrospective case-control study. J Small Anim Pract 2009; 50: 630-635 
33  Pike FS, Berg J, King NW. et al. Gallbladder mucocele in dogs: 30 cases (2000–2002). J Am Vet Med Assoc 2004; 224: 1615-1622 
34  Besso J, Wrigley R, Gliatto J. et al. Ultrasonographic appearance and clinical findings in 14 dogs with gallbladder mucocele. Vet Radiol Ultrasound 2000; 41: 261-271 
35  Aicher KM, Cullen JM, Seiler GS. et al. Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation. PLoS One 2019; 14 e0212638 
36  Keller N. How to Diagnose Hypothyroidism. In World Small Animal Veterinary Association World Congress Proceedings; 2014
37  Pijnacker T, Kooistra HS, Vermeulen CF. et al. Use of basal and TRH-stimulated plasma growth hormone concentrations to differentiate between primary hypothyroidism and nonthyroidal illness in dogs. J Vet Intern Med 2018; 32: 1319-1324 
38  Boretti FS, Sieber-Ruchstuhl NS, Favrot C. et al. Evaluation of recombinant human thyroid-stimulating hormone to test thyroid function in dogs suspected of having hypothyroidism. Am J Vet Res 2006; 67: 2012-2016 
39  Dixon M, Reid SWJ, Mooney CT. Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Vet Rec 1999; 145: 481-487 
40  Kaneko JJ, Tyler WS, Wind A. et al. Clinical applications of the thyroidal I131 uptake test in the dog. J Am Vet Med Assoc 1959; 135: 516-520
41  Kyzar JR, Chester DK, Hightower D. Comparison of T-3, T-4 tests and radioactive iodine uptake determinations in the dog. Vet Med Small Anim Clin 1972; 67: 321-322
42  Adams WH, Daniel GB, Petersen MG. et al. Quantitative 99mTc-pertechnetate thyroid scintigraphy in normal beagles. Vet Radiol Ultrasound 1997; 38: 323-328 
43  Espineira MMD, Mol JA, Peeters ME. et al. Assessment of Thyroid Function in Dogs with Low Plasma Thyroxine Concentration. J Vet Intern Med 2007; 21: 25-32 
44  Shiel RE, Pinilla M, Mcallister H. et al. Assessment of the value of quantitative thyroid scintigraphy for determination of thyroid function in dogs. J Small Anim Pract 2012; 53: 278-285 
45  Daniel GB, Sharp DS, Nieckarz JA. et al. Quantitative thyroid scintigraphy as a predictor of serum thyroxin concentration in normal and hyperthyroid cats. Vet Radiol Ultrasound 2002; 43: 374-382 
46  Balogh L, Thuróczy J, Biksi I. et al. Thyroid volumetric measurement and quantitative thyroid scintigraphy in dogs. Acta Vet Hung 1998; 46: 145-156
47  Daminet S, Ferguson DC. Influence of Drugs on Thyroid Function in Dogs. J Vet Intern Med 2003; 17: 463-463 
48  Wolff EDS, Bilbrough G, Moore G. et al. Comparison of 2 assays for measuring serum total thyroxine concentration in dogs and cats. J Vet Intern Med 2020; 34: 607-615 
49  Hill RC, Fox LE, Lewis DD. et al. Effects of racing and training on serum thyroid hormone concentrations in racing Greyhounds. Am J Vet Res 2001; 62: 1969-1972 
50  Boretti FS, Reusch CE. Endogenous TSH in the diagnosis of hypothyroidism in dogs. Schweiz Arch Tierheilkd 2004; 146: 183-188 
51  Kooistra HS, Diaz-Espineira M, Mol JA. et al. Secretion pattern of thyroid-stimulating hormone in dogs during euthyroidism and hypothyroidism. Domest Anim Endocrinol 2000; 18: 19-29 
52  Reusch CE, Fracassi F, Sieber-Ruckstuhl NS. et al. Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment. J Vet Intern Med 2017; 31: 1643-1648 
53  Skopek E, Patzl M, Nachreiner RF. Detection of autoantibodies against thyroid peroxidase in serum samples of hypothyroid dogs. Am J Vet Res 2006; 67: 809-814 
54  Zeugswetter FK, Hittmair KM, Patzl M. Spuriously high thyroid hormone concentrations measured by chemiluminescent immunoassay attributable to anti-iodothyronine antibodies in a dog. Vet Rec Case Reports. 2016 
55  Refsal KR, Nachreiner RF. Thyroid hormone autoantibodies in the dog: their association with serum concentrations of lodothyronines and thyrotropin and distribution by age, sex, and breed of dog. Canine Pract 1997; 22: 16-17
56  Thacker EL, Refsal KR, Bull RW. Prevalence of autoantibodies to thyroglobulin, thyroxine, or triiodothyronine and relationship of autoantibodies and serum concentrations of iodothyronines in dogs. Am J Vet Res 1992; 53: 449-453
57  Piechotta M, Arndt M, Hoppen HO. Autoantibodies against thyroid hormones and their influence on thyroxine determination with chemiluminescence immunoassay in dogs. J Vet Sci 2010; 11: 191-196 
58  Boretti FS, Sieber-Ruckstuhl NS, Willi B. et al. Comparison of the biological activity of recombinant human thyroid-stimulating hormone with bovine thyroid-stimulating hormone and evaluation of recombinant human thyroid-stimulating hormone in healthy dogs of different breeds. Am J Vet Res 2006; 67: 1169-1172 
59  Boretti FS, Sieber-Ruckstuhl NS, Wenger-Riggenbach B. et al. Comparison of 2 doses of recombinant human thyrotropin for thyroid function testing in healthy and suspected hypothyroid dogs. J Vet Intern Med. 2009 
60  Sauvé F, Paradis M. Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in euthyroid dogs. Can Vet J 2000; 41: 215-219
61  De Roover K, Duchateau L, Carmichael N. et al. Effect of Storage of Reconstituted Recombinant Human Thyroid-Stimulating Hormone (rhTSH) on Thyroid-Stimulating Hormone (TSH) Response Testing in Euthyroid Dogs. J Vet Intern Med 2006; 20: 812-817 
62  Wheeler SL, Husted PW, Rosychuk RA. et al. Serum concentrations of thyroxine and 3,5,3’-triiodothyronine before and after intravenous or intramuscular thyrotropin administration in dogs. Am J Vet Res 1985; 46: 2605-2608
63  Hasler A, Rohner K. Schwerwiegende Reaktionen nach TSH-Stimulationstest beim Hund. Schweiz Arch Tierheilk 1992; 423-427
64  Grünau B, Nolte I, Hoppen HO. Der TRH-Test zur Diagnose der Hypothyreose des Hundes. Kleintierprax 1995; 40: 515-521
65  Frank LA. Comparison of thyrotropin-releasing hormone (TRH) to thyrotropin (TSH) stimulation for evaluating thyroid function in dogs. J Am Anim Hosp Assoc 1996; 32: 481-487 
66  Atkinson K, Aubert I. Myxedema coma leading to respiratory depression in a dog. Can Vet J 2004; 45: 318-320
67  Lewis VA, Morrow CMK, Jacobsen JA. et al. A Pivotal Field Study to Support the Registration of Levothyroxine Sodium Tablets for Canine Hypothyroidism. J Am Anim Hosp Assoc 2018; 54: 201-208 
68  van Dijl IC, Le Traon G, van de Meulengraaf BDAM. et al. Pharmacokinetics of Total Thyroxine after Repeated Oral Administration of Levothyroxine Solution and its Clinical Efficacy in Hypothyroid Dogs. J Vet Intern Med 2014; 28: 1229-1234 
69  Le Traon G, Burgaud S, Horspool LJI. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Ther 2008; 31: 95-101 
70  Iemura R, Toyota M, Micallef MJ. Effects of type of diet on pharmacokinetics of levothyroxine sodium oral solution. Res Vet Sci 2013; 94: 695-697 

71  Eurovet Animal Health BV. Gebrauchsinformation für Forthyron flavour 200 µg Tabletten für Hunde. Im Internet: (Stand: 3.12.2020)

72  Vanmal B, Martlé V, Binst D. et al. Combined atypical primary hypoadrenocorticism and primary hypothyroidism in a dog. Vlaams Diergeneeskd Tijdschr 2016; 85: 355-364 
73  Hrovat A, De Keuster T, Kooistra HS. et al. Behavior in dogs with spontaneous hypothyroidism during treatment with levothyroxine. J Vet Intern Med 2019; 33: 64-71 
74  Rosado B, García-Belenguer S, León M. et al. Blood concentrations of serotonin, cortisol and dehydroepiandrosterone in aggressive dogs. Appl Anim Behav Sci 2010; 123: 124-130 
75  Fatjó J, Stub C, Manteca X. Four cases of aggression and hypothyroidism in dogs. Vet Rec 2002; 151: 547-548 
76  Dixon RM, Reid SWJ, Mooney CT. Treatment and therapeutic monitoring of canine hypothyroidism. J Small Anim Pract 2002; 43: 334-340 
77  Gołyński M, Lutnicki K, Krumrych W. et al. Relationship between Total Homocysteine, Folic Acid, and Thyroid Hormones in Hypothyroid Dogs. J Vet Intern Med 2017; 31: 1403-1405 
78  Stanley E, Appleman E, Schlag A. et al. Relationship between cobalamin and folate deficiencies and anemia in dogs. J Vet Intern Med 2019; 33: 106-113 
79  Ziglioli V, Panciera DL, Troy GC. et al. Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic-Pituitary-Thyroid Axis in Euthyroid Dogs. J Vet Intern Med 2017; 31: 705-710 
80  Panciera DL, MacEwen EG, Atkins CE. et al. Thyroid function tests in euthyroid dogs treated with L-thyroxine. Am J Vet Res 1990; 51: 22-26

[1] Alef M, Driessen B, Hauschild G et al. Leitlinie Anästhesiologische Versorgung beiHund und Katze. Tierarztl Prax Ausg K Kleintiere Heimtiere 2016 Aug 17; 44(4): 261–271
[2] Brodbelt DC, Blissitt KJ, Hammond RA et al. The risk of death: the confidential enquiry into perioperative small animal fatalities. Vet Anaesth Analg 2008 Sep; 35(5): 365–373
[3] Davis H, Jensen T, Johnson A et al. 2013 AAHA/AAFP fluid therapy guidelines for dogs and cats. J Am Anim Hosp Assoc 2013 May–Jun; 49(3): 149–159
[4] Torossian A, Becke K, Bein B et al. S3 Leitlinie „Vermeidung von perioperativer Hypothermie“ (Aktualisierung 2019). AWMF online, im Internet:; Stand: 28.06.2021
[5] Kowalczyk L, Steinbacher R, Dörfelt R. Hypothermie während der Anästhesie – eine unterschätzte Komplikation. Tierärztl Umschau 2010; 65: 384–391
[6] Weidauer J, Alef M. Perioperatives Wärmemanagement. Kleintier konkret 2017; 3: 2–10
[7] Tünsmeyer J, Bojarski I, Nolte I et al. Intraoperative use of a reflective blanket (Sirius rescue sheet) for temperature management in dogs less than 10 kg. J Small Anim Pract 2009 Jul; 50(7): 350–355
[8] Steinbacher R, Mosing M, Eberspächer E et al. Der Einsatz von Infusionswärmepumpen vermindert perioperative Hypothermie bei Katzen. Tierarztl Prax Ausg K Kleintiere Heimtiere 2010 Feb 11; 38(1): 15–22
[9] Camus Y, Delva E, Bossard AE et al. Prevention of hypothermia by cutaneous warming with new electric blankets during abdominal surgery. Br J Anaesth 1997 Dec; 79(6): 796–797
[10] Downing F, Gibson S. Anaesthesia of brachycephalic dogs. J Small Anim Pract 2018 Dec; 59(12): 725–733
[11] Poncet CM, Dupre GP, Freiche VG et al. Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs. J Small Anim Pract 2006 Mar; 47(3): 137–142
[12] Petruccione I, Murison PJ, Flaherty D et al. Comparison between dexmedetomidine and acepromazine in combination with methadone for premedication in brachycephalic dogs undergoing surgery for brachycephalic obstructive airway syndrome. Vet Anaesth Analg 2021 May; 48(3): 305–313
[13] Wallis C, Pesci I, Colyer A et al. A longitudinal assessment of periodontal disease in Yorkshire terriers. BMC Vet Res 2019 Jun 21; 15(1): 207
[14] Oliveira P, Domenech O, Silva J et al. Retrospective review of congenital heart disease in 976 dogs. J Vet Int Med 2011; 25: 477–483
[15] Parker HG, Kilroy-Glynn P. Myxomatous mitral valve disease in dogs: does size matter? J Vet Cardiol 2012; 14(1): 19–29
[16] Evans AT. Anesthesia for severe mitral and tricuspid regurgitation. Vet Clin North Am Small Anim Pract 1992 Mar; 22(2): 465–466
[17] Raffe MR. Anesthesia for severe liver dysfunction. Vet Clin North Am Small Anim Pract 1992 Mar; 22(2): 478–480
[18] Eberspächer-Schweda E. Patient mit Leberproblemen: Insuffizienz und Shunt. In: Eberspächer-Schweda E. AnästhesieSkills. 2. Aufl. Stuttgart: Thieme; 2020: 333–339
[19] Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014; 130(12): 1003–1008
[20] Hay Kraus BL. Anaesthesia for cesarean section in the dog. Vet Focus 2016; 26: 24–31
[21] Traas AM. Resuscitation of canine and feline neonates. Theriogenology 2008 Aug; 70 (3): 343–348

1  Aguirre AL, Center SA, Randolph JF. et al. Gallbladder disease in shetland sheepdogs: 38 cases (1995–2005). J Am Vet Med Assoc 2007; 231 (01) 79-88
2  Pike FS, Berg J, King NW. et al. Gallbladder mucocele in dogs: 30 cases (2000–2002). J Am Vet Med Assoc 2004; 224 (10) 1615-1622
3  Mesich MLL, Mayhew PD, Paek M. et al. Gall bladder mucoceles and their association with endocrinopathies in dogs: A retrospective case‐control study. J Small Anim Pract 2009; 50 (12) 630-635
4  Bennett SL, Milne M, Slocombe RF. et al. Gallbladder mucocoele and concurrent hepatic lipidosis in a cat. Aust Vet J 2007; 85 (10) 397-400
5  Woods KS, Brisson BA, Defarges AM. et al. Congenital duplex gallbladder and biliary mucocele associated with partial hepatic cholestasis and cholelithiasis in a cat. Can Vet J 2012; 53 (03) 269-273
6  Center SA. Diseases of the gallbladder and biliary tree. Vet Clin North Am Small Anim Pract 2009; 39 (03) 543-598
7  Smalle TM, Cahalane AK, Koster LS. Gallbladder mucocoele: A review. J S Afr Vet Assoc 2015; 86 (01) 1318
8  Besso JG, Wrigley RH, Gliatto JM. et al. Ultrasonographic appearance and clinical findings in 14 dogs with gallbladder mucocele. Vet Radiol Ultrasound 2000; 41 (03) 261-271
9  Mealey KL, Minch JD, White SN. et al. An insertion mutation in abcb4 is associated with gallbladder mucocele formation in dogs. Comp Hepatol 2010; 9: 6
10  Kutsunai M, Kanemoto H, Fukushima K. et al. The association between gall bladder mucoceles and hyperlipidaemia in dogs: A retrospective case control study. Vet Journal 2014; 199 (01) 76-79
11  Mori N, Lee P, Muranaka S. et al. Predisposition for primary hyperlipidemia in miniature schnauzers and shetland sheepdogs as compared to other canine breeds. Res Vet Sci 2010; 88 (03) 394-399
12  Kook PH, Schellenberg S, Rentsch KM. et al. Effects of iatrogenic hypercortisolism on gallbladder sludge formation and biochemical bile constituents in dogs. Vet Journal 2012; 191 (02) 225-230
13  Tsukagoshi T, Ohno K, Tsukamoto A. et al. Decreased gallbladder emptying in dogs with biliary sludge or gallbladder mucocele. Vet Radiol Ultrasound 2012; 53 (01) 84-91
14  Center SA. Interpretation of liver enzymes. Vet Clin North Am Small Anim Pract 2007; 37 (02) 297-333
15  Malek S, Sinclair E, Hosgood G. et al. Clinical findings and prognostic factors for dogs undergoing cholecystectomy for gall bladder mucocele. Vet Surg 2013; 42 (04) 418-426
16  Bonczynski JJ, Ludwig LL, Barton LJ. et al. Comparison of peritoneal fluid and peripheral blood ph, bicarbonate, glucose, and lactate concentration as a diagnostic tool for septic peritonitis in dogs and cats. Vet Surg 2003; 32 (02) 161-166
17  Penninck D, dʼAnjou MA. Atlas of small animal ultrasonography. Wiley; 2015
18  Spaulding KA. Ultrasound corner gallbladder wall thickness. Vet Radiol Ultrasound 1993; 34 (04) 270-272
19  Brömel C, Barthez PY, Léveillé R. et al. Prevalence of gallbladder sludge in dogs as assessed by ultrasonography. Vet Radiol Ultrasound 1998; 39 (03) 206-221
20  Hittmair KM, Vielgrader HD, Loupal G. Ultrasonographic evaluation of gallbladder wall thickness in cats. Vet Radiol Ultrasound 2001; 42 (02) 149-155
21  Woods KS, Brisson BA, Defarges AM. Congenital duplex gallbladder and biliary mucocele associated with partial hepatic cholestasis and cholelithiasis in a cat. Can Vet J 2012; 53 (03) 269-273
22  Moentk J, Biller DS. Bilobed gallbladder in a cat: Ultrasonographic appearance. Vet Radiol Ultrasound 1993; 34 (05) 354-356
23  Thiel C, Steinbach S, Schmidt M. et al. Extrahepatic biliary atresia in a 4‐week‐old pug. Vet Surg 2015; 44 (01) 35-40
24  Kamishina H, Katayama M, Okamura Y. et al. Gallbladder agenesis in a chihuahua. J Vet Med Sci 2010; 72 (07) 959-962
25  Austin B, Tillson DM, Kuhnt LA. Gallbladder agenesis in a maltese dog. J Am Anim Hosp Assoc 2006; 42 (04) 308-311
26  Ramstedt KL, Center SA, Randolph JF. et al. Changes in gallbladder volume in healthy dogs after food was withheld for 12 hours followed by ingestion of a meal or a meal containing erythromycin. Am J Vet Res 2008; 69 (05) 647-651
27  DeMonaco SM, Grant DC, Larson MM. et al. Spontaneous course of biliary sludge over 12 months in dogs with ultrasonographically identified biliary sludge. J Vet Int Med 2016; 30 (03) 771-778
28  Choi J, Kim A, Keh S. et al. Comparison between ultrasonographic and clinical findings in 43 dogs with gallbladder mucoceles. Vet Radiol Ultrasound 2014; 55 (02) 202-207
29  Peters LM, Glanemann B, Garden OA. et al. Cytological findings of 140 bile samples from dogs and cats and associated clinical pathological data. J Vet Int Med 2016; 30 (01) 123-131
30  Guess SC, Harkin KR, Biller DS. Anicteric gallbladder rupture in dogs: 5 cases (2007–2013). J Am Vet Med Assoc 2015; 247 (12) 1412-1414
31  Mayhew ID, Mehler SJ, Radhakrishnan A. Laparoscopic cholecystectomy for management of uncomplicated gall bladder mucocele in six dogs. Vet Surg 2008; 37 (07) 625-630
32  Norwich A. Gallbladder mucocele in a 12-year-old cocker spaniel. Can Vet J 2011; 52 (03) 319-321
33  Walter R, Dunn ME, dʼAnjou M-AA. et al. Nonsurgical resolution of gallbladder mucocele in two dogs. J Am Vet Med Assoc 2008; 232 (11) 1688-1693


1 Cornell K. Wound Healing. In: Spencer J, Tobias KM. eds. Veterinary Surgery: Small Animal Expert Consult (Vol 1). 2nd ed. St. Louis, Missouri: Saunders Elsevier; 2017
2 Pavletic MM. Basic Principles of Wound Healing. In: Pavletic MM. ed. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
3 Vogt S. Wundinfektionen bei Hund und Katze [Dissertation]. Gießen: VVB Laufersweiler; 2013
4 Pavletic MM. Basic Principles of Wound Management. In: Pavletic MM. ed. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
5 Brown CD. Wound Infections and Antimicrobial Use. In: Spencer J, Tobias KM. eds. Veterinary Surgery: Small Animal Expert Consult (Vol 1). 2nd ed. St. Louis, Missouri: Saunders Elsevier; 2017
6 Campbel BGl. Bandages and Drains. In: Spencer J, Tobias KM. eds. Veterinary Surgery: Small Animal Expert Consult (Vol 1). 2nd ed. St. Louis, Missouri: Saunders Elsevier; 2017
7 Stull JW, Weese JS. Hospital-associated infections in small animal practice. Vet Clin North Am Small Anim Pract 2015; 45 (02) 217-233
8 Meyers B, Schoemann JP, Goddard A. et al. The bacteriology and antimicrobial susceptibility of infected and non-infected dog bite wounds: Fifty cases. Vet Microbiol 2008; 127: 360-368
9 Guardabassi L, Prescott JF. Antimicrobial stewardship in small animal veterinary practice: from theory to practice. Vet Clin North Am Small Anim Pract 2015; 45 (02) 361-376
10 Devriendt N, de Rooster H. Initial management of traumatic wounds. Vet Clin North Am Small Anim Pract 2017; 47 (06) 1123-1134
11 Buffa EA, Lubbe AM, Verstraete FJ. et al. The effects of wound lavage solutions on canine fibroblasts: an in vitro study. Vet Surg 1997; 26 (06) 460-466
12 Hirsch T, Jacobsen F, Rittig A. et al. A comparative in vitro study of cell toxicity of clinically used antiseptics. Hautarzt 2009; 60 (12) 984-991
13 Stanley BJ. Open Wounds. In: Spencer J, Tobias KM. eds. Veterinary Surgery: Small Animal Expert Consult. (Vol 2). 2nd ed. St. Louis, Missouri: Saunders Elsevier; 2017
14 Pavletic MM. Wound Care Products and Their Use. In: Pavletic MM. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
15 Pavletic MM.. Dressings, Bandages, External Support, and Protective Devices. In: Pavletic MM. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
16 Pavletic MM. Common Complications in Wound Healing. In: Pavletic MM. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
17 Pavletic MM. Management of Specific Wounds. In: Pavletic MM. Atlas of Small Animal Wound Management and Reconstructive Surgery. 3rd ed. Hoboken: Wiley-Blackwell; 2010
18 Tobias KM, Ayers J. Wound management in action: case presentations. Procedures Pro/NAVC Clinicianʼs Brief 2012; 61-66
19 Doyle R. Making Ends Meet: Wound Management and Closure in Dogs and Cats. CVE Soft Tissue Surgery 2. Dublin: VICAS; 2012: 1-52
20 Kirkby KA, Wheeler J, Farese J. et al. Surgical views: Vacuum-assisted wound closure: application and mechanism of action. Compend Contin Educ Vet 2009; 31 (12) E1-E5 E7
21 Thompson E. Debridement techniques and non-negative pressure wound therapy wound management. Vet Clin North Am Small Anim Pract 2017; 47 (06) 1181-1202
22 Demaria M, Stanley BJ, Hauptman JG. et al. Effects of negative pressure wound therapy on healing of open wounds in dog. Vet Surg 2011; 40: 658-669
23 Stanley BJ. Negative pressure wound therapy. Vet Clin North Am Small Anim Pract 2017; 47 (06) 1203-1220
24 von Woedtke T, Schmidt A, Bekeschus S, Wende K. Wissenschaftliche Grundlagen, Stand und Perspektiven der Plasmamedizin. In: Metelmann HR, von Woedtke T, Weltmann KD. Plasmamedizin: Kaltplasma in der medizinischen Anwendung. Berlin: Springer; 2016
25 Heimke A. Niedertemperaturplasma: Eigenschaften, Wirkungen und Gerätetechnik. In: Metelmann HR, von Woedtke T, Weltmann KD. Plasmamedizin: Kaltplasma in der medizinischen Anwendung. Berlin: Springer; 2016
26 Daeschlein G. Antimikrobielle Wirksamkeit von Plasma. In: Metelmann HR, von Woedtke T, Weltmann KD. Plasmamedizin: Kaltplasma in der medizinischen Anwendung. Berlin: Springer; 2016
27 Tiede R, Emmer S. Plasmabehandlung von Wunden. In: Metelmann HR, von Woedtke T, Weltmann KD. Plasmamedizin: Kaltplasma in der medizinischen Anwendung. Berlin: Springer; 2016


[157] C. J. Bailey, Susan L. Turner, K. J. Jakeman, W. A. Hayes “Effect of Coprinus comatus on plasma glucose concentrations in mice.” Planta Med 1984; 50: 525–526 PMID: 23 603 082
[158] Ding Z., Lu Y., Lu Z., Lv F., Wang Y., Bie X., Wang F., Zhang K. “Hypoglycaemic effect of comatin, an antidiabetic substance separeted from Coprinus comatus broth, on alloxan-induced-diabetic rats” Food Chemistry 2010, Volume 121, P. 39–43
[159] Dotan N., Wasser SP., Mahajna J. “Inhibition of the androgen receptor activity by Coprinus comatus substances.” Nutr Cancer. 2011 Nov; 63(8):1316– 27. PMID: 21981 678
[160] Ehssan H.O., Saadabi M., Saadabi A.M. “Screening of Antimicrobial Activity of Wild Mushrooms from Khartoum State of Sudan” 2012 Microbiology Journal 2 (2): 64–69.
[161] Fan J., Zhang J., Tang Q., Liu Y., Zhang A., Pan Y. “Structural elucidation of a neutral fucogalactan from the mycelium of Coprinus comatus.” Carbohydr Res. 2006 Jul; 341(9): 1130–4 PMID: 16 678 806
[162] Han C, Yuan J, Wang Y, Li L. “Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium.” J Trace Elem Med Biol. 2006; 20(3): 191–6 PMID: 16 959 596
[163] Jiang XG., Lian MX., Han Y., Lv SM. “Antitumor and immunomodulatory activity of a polysaccharide from fungus Coprinus comatus” (Mull.:Fr.) Gray. Int J Biol Macromol. 2013 Jul; 58: 349–53. PMID: 23 603 082
[164] Li Bo, Lu Fei, Sho X., Nah H., Li B. “Antioxidant Properties of Cap and Stripe from Corpinus comatus” Molecules 2010, 15, 1473–1486.
[165] Li B., Lu F., Suo XM. “Glucose lowering activity of Coprinus comatus.” Agro Food Industry Hi-Tech 21: 15–17
[166] List Ph. H., “Occurrence of ergothioneine in shaagymane, Coprinus comatus” Arch. Pharm. Ber. Dtsch. Pharm. Ges. 1957, 62, 517–520
[167] List Ph. H., “Biogene Amine und Aminosäuren des Schopftintlings, Coprinus comatus GRAY” Inst. Für Pharmazie und Lebensmittelchemie der Uni. Würzburg; Archiv der Pharmazie, 1958, Vol: 291 (10): 502–513.
[168] Mikiashvili N., Elisashvili V., Wasser S., Nevo E. “Comparative Study of Lectin Activity of Higher Basidiomycetes.” International Journal of Medicinal Mushrooms, 2006, Volume 8, Issue 1, Page 31–38
[169] Ozalp FO., Canbek M., Yamac M., Kanbak G., Van Griensven LJ., Uyanoglu M., Senturk H., Kartkaya K., Oglakci A. “Consumption of Coprinus comatus polysaccharide extract causes recovery of alcoholic liver damage in rats.” Pharm Biol. 2014 Mar. PMID: 24 597 653
[170] Popović M., Vukmirović S., Stilinović N., Capo I., Jakovljević V. “Anti-oxidative activity of an aqueous suspension of commercial preparation of the mushroom Coprinus comatus.” Molecules. 2010 Jun; 15(7):4 564–71. PMID: 20 657 376
[171] Srivastava M. P., Sharma N. “Antimicrobial Activity of Basidiocarp of Some Basisiomycetes Strains against Bacteria and Fungi” 2011 Uni. of Lucknow, India. J Mycol Plant Pathol, Vol. 41, No. 2
[172] Tsai S. Y., Tsai H. L., Mau J. L. “Antioxidant properties of Coprinus comatus” J. Food Biochem. 2009, 33, 368–389
[173] Tsai H.-L., Tsai S.-Y., Mau J.-L. “Nonvolatile Taste Components of Fruit Bodies and Mycelia of Shaggy Ink Cap Mushroom Coprinus comatus (O.F. Müll.: Fr.) Pers. (Agaricomycetideae)” International Journal of Medicinal Mushrooms, 2007, Volume 9, Issue 1, Page 47–55
[174] Wang F., Ding ZY., Zhang KC. “Inhibitory Effects of fermented broth of coprinus comatus feeding with different traditional Chinese medicines on alphaglucosidase and non-enzymatic glycosylation.” Chinese Journal of Pharmaceuticals 2006; 37(6): 384–7
[175] Zaidman BZ., Wasser SP., Nevo E., Mahajna J. “Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells.” Mol Biol Rep. 2007 Mar 13 PMID: 17 431 821
[176] Zenkova V.A., Efremenkova O.V., Ershova E.Y., Tolstych I.V., Dudnik Y.V. “Antimicrobial Activity of Medicinal Mushrooms from Genus Corpinus (Fr.) S.F. Gray” 2003 International Journal of Mushrooms, Vol.5
[570] Cohen N., Cohen J., Asatiani MD., Varshney VK., Yu HT., Yang YC., Li YH., Mau JL., Wasser SP. “Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms.” Int J Med Mushrooms. 2014; 16(3):273–91. PMID: 24 941 169